Diagnostic Artificial Intelligence Research Articles

Innovative Diagnostic Solutions in Hemostasis

Hemostasis describes the process of blood clotting homeostasis. Hemostasis reflects a balance of procoagulant and anticoagulant mechanisms that aim to prevent both bleeding and thrombosis. If hemostasis is disrupted, and bleeding or thrombosis occur, then laboratory testing may ensue to either diagnose the reason for bleeding or thrombosis, or to manage patients under therapy or treatment for bleeding or thrombosis. A wide range of tests of hemostasis are available to laboratories and to clinicians, from routine coagulation assays to specialized hemostasis assays and platelet function. In the current narrative review, we highlight some of the history of innovative diagnostic solutions, such as the integration of chemiluminescence and flow cytometry in the hemostasis diagnostic armamentarium, as well as providing a glimpse to the possible future of diagnostic hemostasis testing. Future directions include the potential for artificial intelligence in diagnostics, the development of more global test systems that can assess both primary and secondary hemostasis, and several innovations to enable the ongoing evolution of therapies to rebalance hemostasis and requiring precise monitoring. This review underscores the ongoing need for innovation to enhance the diagnostic landscape of hemostasis, ensuring better patient outcomes through more accurate and efficient diagnostic methods.

Applications of integrating artificial intelligence and big data: A comprehensive analysis

Abstract The integration of artificial intelligence (AI) and big data technologies has the potential to revolutionize various industries, yet there are complexities and challenges associated with their implementation. This comprehensive study aims to investigate the combined impact of AI and big data on operational efficiency, precision, and security across multiple sectors. By utilizing a methodological analysis of 105 peer-reviewed articles sourced from reputable databases, we systematically explore the diverse applications, key innovations, and transformative potential of these technologies. Our findings uncover significant advancements in healthcare diagnostics, drug discovery, personalized education, and smart farming, highlighting how AI enhances big data analytics to drive notable improvements. Specifically, the study reveals the accuracy of AI in healthcare diagnostics, the efficiency of big data in drug discovery, the personalization of learning experiences through AI in education, and the sustainability advancements in agriculture through smart farming. These results underscore a substantial shift toward more sophisticated data-driven decision-making and operational processes facilitated by the integration of AI and big data. This shift addresses the initial research problem and makes a significant contribution to both academic and practical understanding of the role these technologies play in shaping the future of industry operations. The study concludes that while AI and big data integration offers substantial benefits, addressing associated challenges is crucial for maximizing their impact.

AI in Biomedical Imaging and Diagnostics

Advances in artificial intelligence (AI) and synthetic biology have profoundly influenced biomedical research, creating transformative opportunities in imaging, diagnostics, and therapeutic engineering. In biomedical imaging, AI-driven algorithms enhance precision and accuracy, enabling automated analysis of complex datasets, real-time imaging insights, and identification of disease biomarkers. Meanwhile, synthetic biology redefines cellular engineering, particularly in T-cell research, by enabling customized functionalities, such as precision-targeted antigen recognition and tunable immune responses. The integration of AI into T-cell engineering amplifies these capabilities, facilitating the design and optimization of synthetic circuits, predictive modeling of cellular behaviors, and dynamic monitoring of therapeutic outcomes. This interdisciplinary approach is revolutionizing diagnostics and immunotherapy by streamlining the identification of disease-specific markers, improving diagnostic accuracy, and enabling real-time modulation of T-cell functionality within the tumor microenvironment. By combining AI-powered insights with synthetic biology's ability to engineer living systems, this research aims to address critical challenges in disease treatment, including tumor heterogeneity and immune evasion. This work explores the synergistic application of AI and synthetic biology in biomedical imaging and T-cell engineering, highlighting state-of-the-art technologies, their therapeutic potential, and the future landscape of personalized medicine.

AI-Powered Diagnostics: Revolutionizing Early Disease Detection

Artificial Intelligence (AI) is reshaping the healthcare landscape by enhancing early disease detection and improving diagnostic accuracy. By leveraging machine learning and deep learning techniques, AI can process vast amounts of medical data, identify patterns, and assist clinicians in making faster, more accurate diagnoses. This paper examines the role of AI in medical diagnostics, with a focus on early detection of chronic diseases, such as cancer and cardiovascular conditions, through case studies. It also highlights the challenges, including data privacy concerns, algorithmic bias, and the need for regulatory frameworks to ensure safe AI implementation. Despite these hurdles, AI-powered diagnostics hold the potential to revolutionize healthcare by reducing costs, improving patient outcomes, and advancing personalized medicine. Keywords: Artificial Intelligence (AI), Early Disease Detection, AI Diagnostics, Machine Learning, Deep Learning.

Artificial Intelligence in Medical Diagnostics

Artificial intelligence (AI) is an essential tool in the medical sector that contributes significantly to medical imaging, medical pathology, histology, genomic study, predictive analysis, etc. It is being increasingly used not only in breast and lung cancer diagnosis and screening, and genetic disease identification but also in personalized decision-making during the treatment of these diseases. The quality and availability of unbiased data is a key challenge. Algorithmic bias and interpretability are significant concerns as well. Improving the use of AI in medical diagnostics could be achieved through continuous monitoring, access to highly accurate datasets, and timely intervention by healthcare professionals. J Bangladesh Coll Phys Surg 2024; 42: 379-382

Inteligentna rewolucja w medycynie - zastosowanie sztucznej inteligencji (AI) w medycynie: przegląd, korzyści i wyzwania

Artificial Intelligence (AI) has the potential to revolutionize medical diagnostics by offering new opportunities for accuracy, efficiency, and accessibility in healthcare. This article examines the benefits of implementing AI in diagnostics, such as enhanced diagnostic precision, faster clinical decision-making, cost reduction, and increased access to healthcare. It also discusses the challenges associated with AI implementation, including ethical, legal, and technical issues. The future of AI in medicine may bring further technological advancements and personalized therapy, but it also requires addressing regulatory and ethical concerns.

THE ETHICS OF AI AND AUTOMATED DECISION-MAKING SYSTEMS

As artificial intelligence (AI) and automated decision-making systems become more advanced and prevalent, they raise significant ethical concerns that need to be carefully considered. These technologies have the potential to revolutionize various fields, from healthcare to finance, but they also pose risks if not developed and deployed responsibly. From predictive policing and risk assessment tools in the criminal justice system, to automated resume screening and hiring at companies, to medical diagnostic AI - automated decision systems are shaping profound aspects of our society. Keywords: Ethics of AI,Automated Decision Making System

Making inroads in the Indian AI imaging market

Research methodology This case study involves interviews with radiologists of various hospitals and with company personnel. Both primary and secondary data sources have been used. The first-hand perspective from the radiologists highlighted the challenges they face concerning time and the patient load. The company personnel highlighted using machine learning for used cases to make the platform more robust and accurate. This case has been tested with MBA students. Case overview/synopsis An emerging health-care artificial intelligence (AI) start-up, DeepTek.AI, wants to expand its reach in the radiology market. The company intends to leverage technology to assist radiologists in diagnostics. India's health-care sector faces the challenge of needing more trained doctors and nurses to meet the ever-increasing needs of patients. This case study revolves around the radiologists' concerns about implementing the new technology and its ease of use. The features and benefits of integrating AI in diagnostics are the need of the hour, but the reliability of results needs to be ascertained for adopting it. Complexity academic level This case was written for marketing applications and practices, trends in marketing, marketing strategy and technology adoption in marketing courses at the post-graduate level. Consumer adoption of finance, hospitality, travel and health-care technology is vital for increasing the company's market share and growth prospects. The students will have an opportunity to understand the challenges and the opportunities.

Barriers and facilitators to implementing imaging-based diagnostic artificial intelligence-assisted decision-making software in hospitals in China: a qualitative study using the updated Consolidated Framework for Implementation Research

ObjectivesTo identify the barriers and facilitators to the successful implementation of imaging-based diagnostic artificial intelligence (AI)-assisted decision-making software in China, using the updated Consolidated Framework for Implementation Research (CFIR) as...

Влияние нарушений качества рентгенографических исследований органов грудной клетки на работу врачей-рентгенологов и диагностического искусственного интеллекта.

When performing radiographic studies, quality violations and errors periodically occur, making it difficult for an image to be interpreted and described by both a radiologist and software based on artificial intelligence technology. Incorrect filling of meta-information in DICOM format headers may be a separate problem for diagnostic artificial intelligence. Purpose: determination of quality violations of the chest x-ray examinations, which most strongly impede the work of radiologists and diagnostic software based on artificial intelligence in the conditions of the Moscow city health care system. Material and methods. To study the impact of the quality of x-ray examinations on the work of a radiologist, an online survey was conducted among radiologists, employees of the Moscow reference center for radiation diagnostics. To study the impact of the quality of x-ray examinations on the work of AI-based software, an analysis of the results of processing diagnostic studies according to the modalities chest x-ray and lung fluorography for the 4th quarter of 2023 by artificial intelligence services was carried out as part of an “Experiment on the use of innovative computer vision technologies for medical image analysis and subsequent applicability in the healthcare system of Moscow”. Results. The survey involved 172 radiologists. The most common quality violations by doctors are incompleteness of chest coverage and asymmetric position of the patient, as well as violations of image clarity / contrast. At the same time, the incompleteness of the chest coverage causes the greatest difficulties in interpreting the study for doctors with up to 5 years of experience. For more experienced doctors, the greatest difficulties are caused by violations of the clarity and contrast of images. The main problems hindering the description of studies by AI-services are non-filling or incorrect filling of meta-information about the study stored in DICOM format, as well as violations of the patient’s laying and positioning. Conclusion. The problems we have identified indicate the need for more careful adherence to the methodology of conducting diagnostic studies, especially with regard to filling out meta-information about the study. AI-based software developers need to evaluate the performance of their solutions based on the developed testing and monitoring methodology.

Predictors of mortality by an artificial intelligence enhanced electrocardiogram model for cardiac amyloidosis.

We aim to determine if our previously validated, diagnostic artificial intelligence (AI) electrocardiogram (ECG) model is prognostic for survival among patients with cardiac amyloidosis (CA). A total of 2533 patients with CA (1834 with light chain amyloidosis (AL), 530 with wild-type transthyretin amyloid protein (ATTRwt) and 169 with hereditary transthyretin amyloid (ATTRv)] were included. An amyloid AI ECG (A2E) score was calculated for each patient reflecting the likelihood of CA. CA stage was calculated using the European modification of the Mayo 2004 criteria for AL and Mayo stage for transthyretin amyloid (ATTR). Risk of death was modelled using Cox proportional hazards, and Kaplan-Meier was used to estimate survival. Median age of the cohort was 67 [inter-quartile ratio (IQR) 59, 74], and 71.6% were male. The median overall survival for the cohort was 35.6months [95% confidence interval (CI) 32.3, 39.5]. For AL, ATTRwt and ATTRv, respectively, median survival was 22.9 (95% CI 19.2, 28.2), 47.2 (95% CI 43.4, 52.3) and 61.4 (95% CI 48.7, 75.9) months. On univariate analysis, an increasing A2E score was associated with more than a two-fold risk of all-cause death. On multivariable analysis, the A2E score retained its importance with a risk ratio of 2.0 (95% CI 1.58, 2.55) in the AL group and 2.7 (95% CI 1.81, 4.24) in the ATTR group. Among patients with AL and ATTR amyloidosis, the A2E model helps to stratify risk of CA and adds another dimension of prognostication.

Enhancing cervical cancer cytology screening via artificial intelligence innovation

A double-check process helps prevent errors and ensures quality control. However, it may lead to decreased personal accountability, reduced effort, and declining quality checks. Introducing an artificial intelligence (AI)-based system in such scenarios could effectively address the risk of oversights. This study introduces an innovative AI-integrated workflow for cervical cytology screening that substantially improves efficiency and reduces the burden on cytologists. The AI model prioritizes cases for review based on anomaly scores and streamlines the first screening process to approximately 10 s per case. The model enhances the identification of high-risk cases via detailed microscopic observation, high anomaly scores cases, and a targeted review of low-score cases. The workflow highlights its capability for rapid, accurate, and less labor-intensive evaluations, demonstrating the potential to transform cervical cancer screening. This study highlights the importance of AI in modern medical diagnostics, particularly in areas with a high demand for accuracy and efficiency.

Accuracy of Autonomous Artificial Intelligence-Based Diabetic Retinopathy Screening in Real-Life Clinical Practice.

Background: In diabetic retinopathy, early detection and intervention are crucial in preventing vision loss and improving patient outcomes. In the era of artificial intelligence (AI) and machine learning, new promising diagnostic tools have emerged. The IDX-DR machine (Digital Diagnostics, Coralville, IA, USA) represents a diagnostic tool that combines advanced imaging techniques, AI algorithms, and deep learning methodologies to identify and classify diabetic retinopathy. Methods: All patients that participated in our AI-based DR screening were considered for this study. For this study, all retinal images were additionally reviewed retrospectively by two experienced retinal specialists. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were calculated for the IDX-DR machine compared to the graders' responses. Results: We included a total of 2282 images from 1141 patients who were screened between January 2021 and January 2023 at the Jules Gonin Eye Hospital in Lausanne, Switzerland. Sensitivity was calculated to be 100% for 'no DR', 'mild DR', and 'moderate DR'. Specificity for no DR', 'mild DR', 'moderate DR', and 'severe DR' was calculated to be, respectively, 78.4%, 81.2%, 93.4%, and 97.6%. PPV was calculated to be, respectively, 36.7%, 24.6%, 1.4%, and 0%. NPV was calculated to be 100% for each category. Accuracy was calculated to be higher than 80% for 'no DR', 'mild DR', and 'moderate DR'. Conclusions: In this study, based in Jules Gonin Eye Hospital in Lausanne, we compared the autonomous diagnostic AI system of the IDX-DR machine detecting diabetic retinopathy to human gradings established by two experienced retinal specialists. Our results showed that the ID-x DR machine constantly overestimates the DR stages, thus permitting the clinicians to fully trust negative results delivered by the screening software. Nevertheless, all fundus images classified as 'mild DR' or greater should always be controlled by a specialist in order to assert whether the predicted stage is truly present.

Measurement of Cardiothoracic Ratio on Chest X-rays Using Artificial Intelligence-A Systematic Review and Meta-Analysis.

Background: Chest X-rays (CXRs) are pivotal in clinical diagnostics, particularly in assessing cardiomegaly through the cardiothoracic ratio (CTR). This systematic review and meta-analysis evaluate the efficacy of artificial intelligence (AI) in automating CTR determination to enhance patient care and streamline diagnostic processes. They are concentrated on comparing the performance of AI models in determining the CTR against human assessments, identifying the most effective models for potential clinical implementation. This study was registered with PROSPERO (no. CRD42023437459). No funding was received. Methods: A comprehensive search of medical databases was conducted in June 2023. The search strategy adhered to the PICO framework. Inclusion criteria encompassed original articles from the last decade focusing on AI-assisted CTR assessment from standing-position CXRs. Exclusion criteria included systematic reviews, meta-analyses, conference abstracts, paediatric studies, non-original articles, and studies using imaging techniques other than X-rays. After initial screening, 117 articles were reviewed, with 14 studies meeting the final inclusion criteria. Data extraction was performed by three independent investigators, and quality assessment followed PRISMA 2020 guidelines, using tools such as the JBI Checklist, AMSTAR 2, and CASP Diagnostic Study Checklist. Risk of bias was assessed according to the Cochrane Handbook guidelines. Results: Fourteen studies, comprising a total of 70,472 CXR images, met the inclusion criteria. Various AI models were evaluated, with differences in dataset characteristics and AI technology used. Common preprocessing techniques included resizing and normalization. The pooled AUC for cardiomegaly detection was 0.959 (95% CI 0.944-0.975). The pooled standardized mean difference for CTR measurement was 0.0353 (95% CI 0.147-0.0760). Significant heterogeneity was found between studies (I2 89.97%, p < 0.0001), with no publication bias detected. Conclusions: Standardizing methodologies is crucial to avoid interpretational errors and advance AI in medical imaging diagnostics. Uniform reporting standards are essential for the further development of AI in CTR measurement and broader medical imaging applications.

Artificial Intelligence in Urology: Application of a Machine Learning Model to Predict the Risk of Urolithiasis in a General Population.

This research presents our application of artificial intelligence (AI) in predicting urolithiasis risk. Previous applications, including AI for stone disease, have focused on stone composition and aiding diagnostic imaging. AI applications centered around patient-specific characteristics, lifestyle considerations, and diet have been limited. Our study comprised a robust sample size of 976 Chilean participants, with meticulously analyzed demographic, lifestyle, and health data through a comprehensive questionnaire. We developed a predictive model using various classifiers, including logistic regression, decision trees, random forests, and extra trees, reaching high accuracy (88%) in identifying individuals at risk of kidney stone formation. Key protective factors highlighted by the algorithm include the pivotal role of hydration, physical activity, and dietary patterns that played a crucial role, emphasizing the protective nature of higher fruit and vegetable intake, balanced dairy consumption, and the nuanced impact of specific protein sources on kidney stone risk. In contrast, identified risk factors encompassed gender disparities with males found to be 2.31 times more likely to develop kidney stones than females. Thirst and self-perceived dark urine color emerged as strong predictors, with a significant increase in the likelihood of stone formation. The development of predictive tools with AI, in urolithiasis management signifies a paradigm shift toward more precise and personalized health care. The algorithm's ability to process extensive datasets, including dietary habits, heralds a new era of data-driven medical practice. This research underscores the transformative impact of AI in medical diagnostics and prevention, paving the way for a future where health care interventions are not only more effective but also tailored to individual patient needs. In this case, AI is an important tool that can help patients stay healthy, prevent diseases, and make informed decisions about their overall well-being.

Valuing good health care: How medical doctors, scientists and patients relate ethical challenges with artificial intelligence decision-making support tools in prostate cancer diagnostics to good health care.

Artificial intelligence (AI) is increasingly used in health care to improve diagnostics and treatment. Decision-making tools intended to help professionals in diagnostic processes are developed in a variety of medical fields. Despite the imagined benefits, AI in health care is contested. Scholars point to ethical and social issues related to the development, implementation, and use of AI in diagnostics. Here, we investigate how three relevant groups construct ethical challenges with AI decision-making tools in prostate cancer (PCa) diagnostics: scientists developing AI decision support tools for interpreting MRI scans for PCa, medical doctors working with PCa and PCa patients. This qualitative study is based on participant observation and interviews with the abovementioned actors. The analysis focuses on how each group draws on their understanding of 'good health care' when discussing ethical challenges, and how they mobilise different registers of valuing in this process. Our theoretical approach is inspired by scholarship on evaluation and justification. We demonstrate how ethical challenges in this area are conceptualised, weighted and negotiated among these participants as processes of valuing good health care and compare their perspectives.

Interpretation of Artificial Intelligence Models in Healthcare: A Pictorial Guide for Clinicians.

Artificial intelligence (AI) models can play a more effective role in managing patients with the explosion of digital health records available in the healthcare industry. Machine-learning (ML) and deep-learning (DL) techniques are two methods used to develop predictive models that serve to improve the clinical processes in the healthcare industry. These models are also implemented in medical imaging machines to empower them with an intelligent decision system to aid physicians in their decisions and increase the efficiency of their routine clinical practices. The physicians who are going to work with these machines need to have an insight into what happens in the background of the implemented models and how they work. More importantly, they need to be able to interpret their predictions, assess their performance, and compare them to find the one with the best performance and fewer errors. This review aims to provide an accessible overview of key evaluation metrics for physicians without AI expertise. In this review, we developed four real-world diagnostic AI models (two ML and two DL models) for breast cancer diagnosis using ultrasound images. Then, 23 of the most commonly used evaluation metrics were reviewed uncomplicatedly for physicians. Finally, all metrics were calculated and used practically to interpret and evaluate the outputs of the models. Accessible explanations and practical applications empower physicians to effectively interpret, evaluate, and optimize AI models to ensure safety and efficacy when integrated into clinical practice.

Enhancing Prostate Cancer Diagnosis: Artificial Intelligence–Driven Virtual Biopsy for Optimal Magnetic Resonance Imaging-Targeted Biopsy Approach and Gleason Grading Strategy

An optimal approach to magnetic resonance imaging fusion targeted prostate biopsy (PBx) remains unclear (number of cores, intercore distance, Gleason grading [GG] principle). The aim of this study was to develop a precise pixel-wise segmentation diagnostic artificial intelligence (AI) algorithm for tumor detection and GG as well as an algorithm for virtual prostate biopsy that are used together to systematically investigate and find an optimal approach to targeted PBx. Pixel-wise AI algorithms for tumor detection and GG were developed using a high-quality, manually annotated data set (slides n = 442) after fast-track annotation transfer into segmentation style. To this end, a virtual biopsy algorithm was developed that can perform random biopsies from tumor regions in whole-mount whole-slide images with predefined parameters. A cohort of 115 radical prostatectomy (RP) patient cases with clinically significant, magnetic resonance imaging-visible tumors (n = 121) was used for systematic studies of the optimal biopsy approach. Three expert genitourinary (GU) pathologists (Y.T., A.P., A.Q.) participated in the validation. The tumor detection algorithm (aware version sensitivity/specificity 0.99/0.90, balanced version 0.97/0.97) and GG algorithm (quadratic kappa range vs pathologists 0.77-0.78) perform on par with expert GU pathologists. In total, 65,340 virtual biopsies were performed to study different biopsy approaches with the following results: (1) 4 biopsy cores is the optimal number for a targeted PBx, (2) cumulative GG strategy is superior to using maximal Gleason score for single cores, (3) controlling for minimal intercore distance does not improve the predictive accuracy for the RP Gleason score, (4) using tertiary Gleason pattern principle (for AI tool) in cumulative GG strategy might allow better predictions of final RP Gleason score. The AI algorithm (based on cumulative GG strategy) predicted the RP Gleason score of the tumor better than 2 of the 3 expert GU pathologists. In this study, using an original approach of virtual prostate biopsy on the real cohort of patient cases, we find the optimal approach to the biopsy procedure and the subsequent GG of a targeted PBx. We publicly release 2 large data sets with associated expert pathologists’ GG and our virtual biopsy algorithm.

Artificial Intelligence in Medicine: from Diagnosis to Treatment

In recent years, medicine has faced the serious challenge of the covid pandemic, due to which representatives of the health care sector had to mobilize forces and resources to jointly overcome these problems. The rapid development of artificial intelligence, its learning capabilities, and in recent years the creation of a neural network opens up wide possibilities for the use of AI in medicine. Aims: To analyze the modern literature on the use of AI for diagnosis and treatment and to analyze what problems may arise with the uncontrolled introduction of artificial intelligence Methodology: When conducting a literature review, an analysis and generalization of data on the research topic from 2019 to 2024 was carried out. The literature search was carried out by keywords using the PubMed search engine. Results: The literature review demonstrated the use of artificial intelligence in medicine, which has grown significantly in recent years and continues its rapid development, which is associated with the improvement of innovative technologies. The use of artificial intelligence in diagnostics is associated with the use of a neural network, which makes it possible to identify digitized images for rapid diagnosis. The use of artificial intelligence in surgery is reflected in the application of da Vinci. Artificial intelligence has been widely used in anesthesiology. Scientific Novelty: The literature search established that the implementation of artificial intelligence in medicine creates certain challenges related to the protection of personal data, and the possibility of error is not excluded when using AI. Conclusion: The use of AI is promising for diagnosis and treatment and helps doctors quickly make a diagnosis and prescribe treatment, but certain challenges created by artificial intelligence must be solved by implementing more reliable personal data protection systems, as well as control over the information reproduced by artificial intelligence.

ПРАВОВАЯ АРХИТЕКТУРА ВЗАИМОСВЯЗИ ИСКУССТВЕННОГО ИНТЕЛЛЕКТА И ЗАЩИТЫ ПРАВ ПАЦИЕНТОВ ПРИ МЕДИЦИНСКОЙ ДИАГНОСТИКЕ

The study of the legal architecture of the relationship between artificial intelligence and patient protection in medical diagnostics includes a brief overview of the current state of application of artificial intelligence in diagnostic medicine and an analysis of its potential benefits and risks. This article reviews the current regulations governing the use of artificial intelligence in medical diagnostics, including laws, guidelines and best practices, as well as the role of health care regulators and personal data protection. Special attention is paid to the ethical aspects of using artificial intelligence in diagnostics, such as: ensuring patient privacy, protecting medical data, preventing algorithmic bias, and ensuring transparency in the diagnostic decision-making process. Specific examples of implementation of artificial intelligence in diagnostic practice are presented, illustrating both opportunities and challenges associated with this technology, including analysis of successful and unsuccessful cases of implementation. The study describes promising developments in the field of AI diagnostics, including new technologies and trends, and forecasts the evolution of the legal framework in response to these innovations. Finally, it summarizes the results of the study and presents recommendations for improving the legal regulation of artificial intelligence in medical diagnostics, taking into account the need to protect the rights and interests of patients.